--- a
+++ b/clusters/3009knumclusters/clust_27.txt
@@ -0,0 +1,333 @@
+Pregnancy or lactation at the time of study entry; (note: pregnancy testing according to institutional standards for women of childbearing potential must be performed within 2 weeks prior to randomization)
+Pregnancy or lactation at the time of study entry; (Note: pregnancy testing must be performed within 2 weeks prior to randomization according to institutional standards for women of childbearing potential)
+Pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy
+Pregnancy, lactation, or breastfeeding
+Pregnancy
+Pregnancy or lactation at the time of study entry. (Note: Pregnancy testing should be performed within 14 days prior to study entry according to institutional standards for women of childbearing potential.)
+Pregnancy or active breastfeeding
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy:
+Pregnancy
+Pregnancy -
+Pregnancy
+Current pregnancy or lactation
+Pregnancy or breastfeeding.
+Pregnancy
+Pregnancy or lactation at the time of randomization or intention to become pregnant during the study. (Note: Negative serum pregnancy test must be obtained within 14 days prior to randomization).
+Pregnancy (independent of outcome) and/or lactation within 1 year prior to the screening mammogram.
+Pregnancy, lactation, or breastfeeding women.
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding.
+Pregnancy or lactation. Pregnancy is associated with considerable immune suppression and this additional parameter may interfere with the evaluation of dendritic cell induced immune responses in melanoma study subjects. Pregnancy test must be negative on all women of reproductive potential at baseline (within 7 days of entry into the study) and they must agree to use birth control measures while on the study
+Pregnancy (positive serum pregnancy test) or lactation
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy or lactation.
+Pregnancy
+Current lactation
+Pregnancy at the time of enrollment
+Pregnancy or breastfeeding.
+Pregnancy or breastfeeding.
+GENERAL: Pregnancy, lactation, or breastfeeding.
+Pregnancy or lactation.
+Pregnancy or breastfeeding patients.
+Pregnancy, lactation, or breastfeeding.
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy or lactation.
+Pregnancy, lactation, or breastfeeding
+Pregnancy
+Pregnancy (positive pregnancy test) or lactation
+Pregnancy or breastfeeding
+Pregnancy or lactation.
+Pregnancy
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation
+Pregnant or breast-feeding. (While pregnancy is unlikely in view of the disease and previous surgery, subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy [beta-HCG] test and will be using a medically approved contraceptive method).
+Pregnancy
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy, lactation, or breastfeeding
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy
+Pregnancy or lactation
+Patients may not have significant concurrent illness, infection, pregnancy or lactation
+Pregnancy and lactation; refusal to use adequate contraception
+Pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy
+Current pregnancy or lactation
+Pregnancy or breastfeeding
+TREATMENT: Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation at the time of study entry. (Note: Pregnancy testing should be performed within 14 days prior to study entry according to institutional standards for women of childbearing potential.)
+Pregnancy
+Pregnancy (positive pregnancy test) or lactation
+Pregnancy
+If female, no pregnancy
+Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy and lactation
+Pregnancy or breastfeeding.
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Patient pregnancy
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy or lactation at enrollment
+Pregnancy
+Pregnancy
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or lactation.
+Pregnancy or lactation at the time of study entry. (Note: Pregnancy testing should be performed within 14 days prior to study entry according to institutional standards for women of childbearing potential.)
+Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation at the time of randomization or intention to become pregnant during the study; (Note: Pregnancy testing according to institutional standards for women of childbearing potential must be performed within 72 hours prior to randomization)
+Pregnancy (positive pregnancy test) or lactation.
+Pregnancy or inadequate contraception.
+Confirmed or suspected pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy, lactation, or breastfeeding.
+Pregnancy.
+Pregnancy, lactation, or breastfeeding
+Pregnancy or active breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy
+Pregnancy or lactation at the time of study entry (note: pregnancy testing must be performed within 2 weeks prior to randomization according to institutional standards for women of childbearing potential)
+Pregnancy or lactation
+Current pregnancy
+Pregnancy
+Pregnancy
+Pregnancy, lactation, or breastfeeding
+Pregnancy
+Pregnancy
+Pregnancy or lactation at the time of study entry; (note: pregnancy testing must be performed within 2 weeks prior to randomization according to institutional standards for women of childbearing potential)
+Pregnancy
+Current pregnancy
+Donors: Pregnancy
+Pregnancy.
+Pregnancy or lactation
+Pregnancy or breastfeeding.
+Pregnancy or breastfeeding
+Pregnancy or lactation at the time of study entry. (Note: Pregnancy testing must be performed within 14 days prior to randomization according to institutional standards for women of childbearing potential.)
+agree to ongoing pregnancy testing
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy
+Current pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy (due to unknown effects of this therapy on a fetus) or lactation
+Pregnancy or lactation
+Pregnancy, lactation, or inability or unwillingness to use medically acceptable forms of contraception if pregnancy is a risk.
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Known pregnancy, nursing women or positive pregnancy test
+Pregnancy
+Pregnancy (positive pregnancy test) or lactation
+Self-reported pregnancy or breastfeeding or planning a pregnancy within the next two years
+Pregnancy or lactation.
+Pregnancy as determined by pregnancy test or nursing;
+Pregnancy
+Pregnancy
+Pregnancy or lactation at the time of study entry.
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation period
+Pregnancy (positive pregnancy test) or lactation
+Pregnancy or lactation.
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy
+Evidence of pregnancy or lactation period
+Pregnancy or lactation.
+Evidence of pregnancy or lactation period.
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Pregnancy
+Pregnancy or lactation.
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation
+Pregnancy
+Current pregnancy
+Pregnancy
+Pregnancy or breastfeeding.
+Pregnancy or breastfeeding;
+Pregnancy, lactation, or breastfeeding
+Pregnancy and lactation
+Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Women with a confirmed intrauterine pregnancy
+Pregnancy (positive pregnancy test) or lactation
+Pregnancy or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or lactation
+Known pregnancy
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation at the time of registration
+Pregnancy, lactation, or breastfeeding
+Pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation
+For female participants, current pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy;
+Avoid pregnancy
+Pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy or breastfeeding;
+Pregnancy or lactation.
+Pregnancy, lactation, or breastfeeding
+Pregnancy and/or lactation
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy or lactation.
+Pregnancy
+Current pregnancy or lactation
+Pregnancy (positive pregnancy test) or lactation
+Pregnancy or lactation
+Pregnancy or lactation.
+Pregnancy or lactation
+Pregnancy:
+Pregnancy
+Pregnancy or breast-feeding; radiation therapy to the pelvis is contraindicated during any stage of pregnancy
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy, lactation or breastfeeding
+Pregnancy or lactation
+Current pregnancy or breastfeeding
+Pregnancy, lactation, or breastfeeding
+Current pregnancy
+Pregnancy or lactation
+Pregnancy, lactation, or breastfeeding
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy
+Lactation
+Pregnancy or breastfeeding - menstruating females must have a negative pregnancy test prior to study enrollment and agree to repeat pregnancy testing and contraception use per protocol
+Pregnancy
+Pregnancy confirmed by pregnancy test / Lactating women;
+Stage I Arm A: Pregnancy, lactation, or intention to become pregnant or fathering a child during the study
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Known pregnancy
+Candidate for pregnancy
+Current pregnancy
+Pregnancy.
+Pregnancy
+Must be > 1 year from pregnancy, lactation or chemotherapy
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Patients who are pregnant or breastfeeding; patients will be asked about the possibility of pregnancy; a pregnancy test will be obtained for those patients who have been sexually active without using birth control since their last menstrual period; pregnancy status can be confirmed using any of the following: pregnancy test, prior hysterectomy, tubal ligation, use of intra-uterine device (IUD) or Depo-Provera, or if the woman is beyond childbearing age
+Pregnancy or lactation
+Active pregnancy
+Patients who are known to be pregnant or who are breastfeeding; patients will be asked about pregnancy status and a pregnancy test will be performed only if there is a high probability of pregnancy
+Pregnancy
+Current pregnancy
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation
+Currently pregnant or within 3 months post-partum, or unwilling to undergo pregnancy testing or report possible pregnancy promptly
+Pregnancy
+Pregnancy or lactation within the prior 6 months
+Must be more than 1 year from pregnancy, lactation or chemotherapy
+Pregnancy
+Pregnancy or breastfeeding
+Pregnancy or lactation.
+Pregnancy
+Pregnancy
+Pregnancy or lactation
+Current pregnancy or breastfeeding
+Pregnancy or lactation
+Pregnancy
+Greater than 1 year from pregnancy, lactation
+Pregnancy
+Current or planned pregnancy
+Pregnancy or lactation (by history) or positive pregnancy test at screening visit
+Pregnancy
+Have experienced lactation or pregnancy during the previous 12 months
+Must be > 1 year from pregnancy, lactation or chemotherapy
+Current or planned pregnancy
+Pregnancy at any point during the study period OR considering pregnancy during the study period
+Pregnancy
+Pregnancy, breast feeding, or planning pregnancy within 1 year
+Pregnancy or lactation at the time of study registration; (Note: Pregnancy testing according to institutional standards for women of childbearing potential must be performed within 2 weeks prior to study registration)
+Known current pregnancy; a pregnancy test is not required for this exclusion criteria
+Pregnancy
+Pregnancy, or positive pregnancy test
+Pregnancy or lactation. Future plans for pregnancy do not exclude patient participation. Patient should not become pregnant within one month of completion of 18F-DA PET scan
+Pregnancy
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy or lactation
+Pregnancy
+Pregnancy or lactation
+Pregnancy or breastfeeding
+Pregnancy and lactation
+Pregnancy or lactation
+Pregnancy
+Pregnancy;
+Pregnancy or breastfeeding
+Pregnancy
+Pregnancy or active breastfeeding
+Women only: pregnancy or lactation
+Pregnancy or lactation
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy or lactation
+Pregnancy
+Pregnancy
+Pregnancy
+Pregnancy
+Known pregnancy at study Visit 1.
+Pregnancy or breastfeeding
+Self-reported pregnancy or breastfeeding or planning a pregnancy within the next year
+Pregnancy
+Pregnancy (for female patients)
+Pregnancy
+Pregnancy, or positive pregnancy test
+Pregnancy, lactation, or breastfeeding